Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
about
Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma.Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma.Effect of Derris scandens extract on a human hepatocellular carcinoma cell lineThe prognostic values of the peroxiredoxins family in ovarian cancer
P2860
Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@ast
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@en
type
label
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@ast
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@en
prefLabel
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@ast
Peroxiredoxin 4 as an independ ...... lung squamous cell carcinoma.
@en
P2093
P2860
P1476
Peroxiredoxin 4 as an independ ...... e lung squamous cell carcinoma
@en
P2093
Chang Min Choi
Dae Yeul Yu
Hye Jin Park
Hyeong Ryul Kim
Ji An Hwang
Joon Seon Song
Woo Sung Kim
Young Soo Park
P2860
P304
P577
2015-06-01T00:00:00Z